Nihon Chouzai Co Ltd
TSE:3341
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
JP |
Nihon Chouzai Co Ltd
TSE:3341
|
42B JPY | 10.7 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
75.2B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.6B USD | -2.6 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
46.4B BRL | 44.3 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.4B CNY | 30.6 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
912.1B JPY | 18 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.9B SAR | 19.9 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
78.3B MXN | 16.3 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
555.4B JPY | 23.1 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.8B CNY | 24.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.